Biosynthesis, cytotoxicity and antimicrobial effect of silver ganoparticle from polysaccharide extract of Ganoderma lucidum.
Mushroom proteins contain all the essential amino acids and are especially rich in lysine and leucine. The low total fat content and high proportion of polyunsaturated fatty acids relative to the total fatty acids of mushrooms are considered significant contributors to the health value of mushrooms (Chang, 1996). Polysaccharides, Peptidoglycans and triterpenes are three major physiologically active constituents in G. lucidum (Boh et al., 2007). Different compounds that includes Polysaccharides, triterpenoids etc with various biological activities are extracted from mycelia, the fruiting bodies or spores of G. lucidum. However, more than 100 types of polysaccharides isolated from this medicinal mushroom till date, comprise the major source of its biological activity and are linked to possible therapeutic effects (Boh et al., 2007) (Lindequist et al., 2005).
G. lucidum is a popular remedy to treat conditions like chronic hepatitis, hypertension, arthritis, insomnia, bronchitis, asthma, gastric ulcer, diabetes and cancer. It possesses anti-tumor activity and has also been found to inhibit platelet aggregation and to lower blood pressure, cholesterol and blood sugar (Borchers et al, 2004). Ganoderma may affect different stages of cancer development: by inhibition of angiogenesis (formation of new tumor-induced blood vessels, created to supply nutrients to the tumor), by inhibiting migration of the cancer cells called metastasis or by inducing and enhancing apoptosis of tumor cells (Paterson et al .,2006). In clinical trials conducted on humans over the last 40 years, G. lucidum has been used to treat a wide variety of disorders (Sanodiya et al, 2009), including: 1) Nervous system disorders, dizziness, insomnia, anxiety and stress-related concerns. 2) Respiratory tract conditions and asthma. 3) Duodenal ulcers, leukopenia, progressive muscular dystrophy. 4) Mental disease caused by environmental stress and Alzheimer's disease. 5) Hyperlipidemia, diabetes, liver disease and hepatitis.
Nanoparticles are one of the novel drug delivery systems, which can be of potential use in controlled and targeted drug delivering. Due to limited selectivity accompanied by toxicity to normal cells, targeted drug delivery systems can be a suitable solution for most anticancer drugs (Zhao et al., 2007). Nanoparticle approaches to targeted drug delivery for malignant tumours offer new opportunities to improve patient care and quality of life by reducing toxicity related issues (Karwa et al., 2011). Receptor mediated cellular uptake of nanoparticle could be achieved by attaching suitable ligands that recognize tumour associated antigens. The current knowledge on Ganoderma can be exploited to design polymer-Ganoderma conjugate as a tool for sustained and targeted drug delivery. So Ganoderma based nanoparticle (ganoparticles) can be designed for its targeted and sustained release at tumour sites.
Cancer is a worldwide leading cause of death and despite of comprehensive advances in the early diagnosis of the disease and chemotherapy, it remains a major clinical challenge (The cancer cure foundation, 1976). Chemotherapy using cytotoxic anticancer drugs is being practiced but has a lot of side effects and offers little survival benefits for patients. So there is a need to use alternative natural medicine with lesser side effects to cure Cancer. For that reason there has been a search for new chemopreventive and chemotherapeutic agents for which hundreds of plant species including Mushrooms have been evaluated. This has resulted in the isolation of thousands of bioactive molecules that have shown to be having antitumor activity from numerous mushroom species including Ganoderma species. Ganoderma extract is an active constituent of medicinal fungus Ganoderma lucidum and has proved to have numerous pharmacological activities and can act as a potential anticancer agent (Sliva, 2003). Keeping the above fact in view, the aim of the present study was to generate nanoparticles (named as ganoparticles) using Ganoderma lucidum extract and to evaluating its antitumor activity.
MATERIALS AND METHODS
Microorganism and culture maintenance
G. lucidum strain used in the present study was procured from "National Research Centre for Mushrooms", Solan, H.P, India. The stain was aseptically transferred to fresh Potato Dextrose Agar (PDA) slants followed by incubation at 25[degrees]C until confluent growth was achieved. Potato Dextrose Agar media was used for the growth of G. lucidum. These slants were maintained in the active stage by transferring mycelial disks (plugs) aseptically on fresh plates at regular time interval and were stored at 4[degrees]C.
A 6mm Culture plug was taken from the growing edge of a 3 day old culture and were transferred to a conical flask containing 100 ml of PD Broth followed by incubation for a period of 7 days under sterile conditions (Vahabi et al, 2011) . After the growth as in a disk form above the PD Broth, the mycelial biomass was separated from the culture medium by filtration through Whatmann's filter paper. The mycelial biomass was then rinsed with water until the water ran clear and the resulting biomass was dried in an oven at 60[degrees]C for 24 hrs.
Hot water aqueous Extraction
The dried mycelial disk was weighed and grinded to a fine powder using a mortar and pestle. Five grams of dried mycelial powder was treated with hot water for polysaccharide extraction (Chang et al, 2004). Dried biomass powder was transferred into a 250 ml beaker,followed by addition of 100ml water, the mixture was heated at 95 to 100[degrees]C for 2 hours with continuous stirring. After 2 h the filtrate was separated from the mycelial biomass by filtration using Whatmann's filter paper.
Generation of Ganoparticles
Biosynthesis of silver ganoparticles was carried out by taking 10g wet biomass of G lucidum fungus in 100 ml aqueous solution of 1 mM silver nitrate (AgN[O.sub.3]) (Ahmad et al., 2003). The mixture was placed in an orbital Shaker with a temperature of 28[degrees]C for an incubation period of 120 h with a agitation speed of 100 RPM. Silver ganoparticles were produced through reduction of the silver ions to metallic silver. The pale yellow colour of the fungus cells in the reaction mixture was changed to brownish colour, the well known yellowishbrown color of silver nanoparticles arises due to excitation of surface plasmon vibrations (essentially the vibration of the group conduction electrons) in the silver nanoparticles. The appearance of a yellowish brown color in solution containing the biomass is a clear indication of the formation of silver nanoparticles (ganoparticles) (Duran et al., 2005).
Anti-Bacterial activity was analyzed by agar diffusion well variant Method on four of the bacterial species: Staphylococcus aureus, Pseudomonas aeruginosa, Bacillus subtilis and E.coli.
Agar well diffusion method
The zone of inhibition of silver ganoparticles was measured by the agar well diffusion assay (Burns et al., 2000). The inoculum suspensions of the test microorganisms were prepared by using 16 h old cultures adjusted to 108 cfu/mL by referring the 0.5 McFarland standards. Total 20 mL of Nutrient agar medium was poured into each petri plate, and then plates were swabbed with 100 [micro]L inoculum of the test microorganisms and kept for 15 min for adsorption. Wells were bored into the seeded agar plates using a sterile cork borer of diameter (8 mm), and these were loaded with a 100 pL volume with concentration of 5.0 mg/mL of ganoparticles. The incubation of all theplates was carried at 37 [degrees]C for 24 h. antimicrobial activity against the selected organisms was evaluated by measuring the zone of inhibition with zone reader (Hi antibiotic zone scale).
Anti-Tumor Assays MTT Assay
Two lung cancer cell lines A549 & NCIH520 were used to examine the characteristics of MTT (3-(4, 5-dimethylthiazolyl-2)-2, 5-diphenyltetrazolium bromide) which is reduced by metabolically active cells by the action of dehydrogenase enzymes to generate reducing equivalents such as NADH and NADPH. The resulting purple formazan can be solubilized and quantified by spectrophotometer (Panchanathan et al., 2013).
For most tumor cell lines 5,000 cells per well is required to perform proliferation assays, hence viable cells of cell lines A549 and NCIH520 were seeded in 96-well plates in RPMI-1640 Medium and were kept for incubation overnight. When cells reached more than 80% confluence, the medium was replaced and cells were incubated with different concentrations 5,10, 15, 20, 25, 30, 35 and 40 1/4g/100 1/41 of Ganoparticle solution and Crude polysaccharide extract taken from the Stock solution 5mg/ml. The ganoparticle solution and crude polysaccharide extract, at a concentration of stock (5mg/ml) were added as the positive control and cells containing only media were used as blank wells. After 24hrs, the supernatants were removed and cell layers were incubated with MTT Reagent for about 5 h at 37 [degrees]C and 25 [micro]l of the Detergent Reagent was added to dissolve the Formazan Crystals formed (Guoqiang et al., 2012).
The Optical Density (OD) of each well was quantified at 570 nm wavelength by an ELISA Reader. The absorbance of untreated cells was considered as 100%. Each polysaccharide extract and ganoparticle treated well including control wells were assayed in triplicate. percent cell viability and percent cytotoxicity (percent inhibition) of cells exposed to treatments was calculated as:
% Viability=Absorbance of test wells/ Absorbance of control wells x100
(Sample Absorbance/ Control Absorbance x100)
% Cytotoxicity = 100- %Viability
Effects of Tryphan Blue on Cell Viability in Human Lung Cancer cells
Cell suspension of 106 cells/ml was prepared in serum free media to be assayed and 1: 1 dilution of the suspension was prepared using a 0.4% trypan blue solution. Three wells were prepared, the first was kept as control contaning only cells , Second well containing cells was treated with ganoparticles and the third well containing cells treated with polysaccharide extract, the mixing was performed in microtitre plate (Masters et al., 2000a).
The solution with cells and trypan blue was added to the counting chambers of a haemocytometer, followed by counting of stained cells and total number of cells. The calculated Percentage of unstained cells was represented as the Percentage Viable cells (Masters, 2000b). Cell viability was calculated as the Number of viable cells divided by the total number of cells within the grids on the heamocytometer.
% Viability = Total number of viable cells per ml/ Total no. of cells per ml x 100.
(No. of live cells/ Total cell count x 100)
Live Cell Count (Average live cell per large square) = 1st+2nd+3rd+4th outer squares live cell count/ 4. Cell Density (cells/ml)=Average live cells x Dilution factor/ Volume of Square (ml) As 1:1 Dilution, dilution factor is 2.
RESULTS AND DISCUSSION
Extracellular Synthesis of AgNPs
In the Present study, G. lucidum extract was used for the Synthesis of AgNPs (Fig 1). The mycelial polysaccharide extract was treated with silver nitrate, It was observed that the extract had a Pale-yellow color before reaction with the silver ions, which changed to a brownish color on completion of the reaction (Ahmed et al., 2003). The appearance of a yellowish-brown color in solution containing the extract was a clear indication of the formation of AgNPs in the reaction mixture and was due to the excitation of surface plasmon vibrations in the NPs (Sastry et al., 1997). The color change indicates that G. lucidum mycelial extract could be used as a reducing and stabilizing agent for AgNPs synthesis (Patil et al., 1998). The color formation is similar to the results found by (Vahabi et al., 2011) and (Hemath et al., 2010).
Effect of AgNPs on human lung cancer cells
The Cell Viability assay is one of the important parameters for toxicology analysis that explains the cellular responses to toxic materials and can provide information on cell death, survival and their metabolic activities (AshaRani et al., 2009). Human Lung cancer cell lines A549 and NCIH520 were treated with AgNPs and Crude Polysaccharide extract for 24 hrs. To examine the effect of AgNPs and crude polysaccharide extract on mitochondrial activity, cells were treated with various concentrations of test compounds ranging from 5[micro]g/100[micro]l to 40[micro]g/100[micro]l. The absorbance was measured at 570nm in a Microtitre plate Reader, %
Viability and % Inhibition was calculated for each Concentration using Control. The results are graphically represented in Fig. 2-4. The Percentage growth inhibition was found to be increasing with increasing concentration of ganoparticles and percentage cell viability was found to be decreasing with increasing concentration of ganoparticles and crude polysaccharide extract. however, ganoparticles treated cells showed much decreased metabolic activity than crude polysaccharide extract treated cells. Our results are in agreement with the previous report of Park et al. (2011). AgNPs and Crude polysaccharide extract inhibited the proliferation of A549 and NCIH520 following dose and time dependent manner. However, A549 was found to be more resistant than NCIH520, Ganoparticles, when compared to polysaccharide extract, were found to be more effective in suppressing the growth of cancer cells in comparison to crude polysaccharide extract. Our results are in agreement with the previous report of anti tumor effect of ganoderma neo-japonicum in suppressing the growth of breast cancer cells (Gurunathan et. al, 2013). Guoqiang et.al (2012) also reported synthesis of silver nanoparticles and their antiproliferation against human lung cancer cells. Tryphan Blue Assay
Percentage of viable cells can be obtained by performing trypan blue dye exclusion technique. Tryphan Blue is an essential dye, used in estimating the number of viable cells present in a population (Phillips et al., 1957). Table 1 shows the percent cell viability of A549 and NCIH520 cell line. Ganoparticle treated cells lines shows 50-55% viability (1.1-1.4x105cells/ml), whereas crude polysaccharide extract treated cells were found to be 62-67% viable (1.3-1.7x[10.sup.5] cells/ml). In a similar study, Patel et.al (2009) reported the cytotoxicity activity of Solanum nigrum extract against HeLa cell line and Vero cell line
Antibacterial effect of AgNPs and crude extract
Table 2 show the antibacterial effect of ganoparticles and crude polysaccharide extract.. Antibacterial potential of the polysaccharide extract and silver ganoparticles was estimated by agar well diffusion method (Irshad et al., 2012) and the zone of inhibition was observed against all test organisms with largest zone of inhibition observed against Staphylococcus aureus (22mm) followed by Bacillus subtilis (20mm) Escherichia coli (19mm) and Pseudomonas aeruginosa. A larger zone of inhibition was observed in the presence of ganoparticles than Crude polysaccharide extract suggesting that G lucidum AgNPs are more effective against bacterial strains than its extract.
Ganoderma extract is an active constituent of medicinal fungus Ganoderma lucidum & has proved to have numerous pharmacological activities and it can act as a potential anticancer agent. As tumor growth and progression require angiogenesis, an agent which acts as anti-angiogenic can arrest tumor growth to a defined location. It could further inhibit metastasis of the tumor tissue to other part. Further effort should be made to enhance the bioactivity of Ganoderma so as to increase its potency. This promising research about generation of Ganoparticles using G. lucidum extract & evaluation of its anti-proliferatory effect and antitumor properties would be considered as a good research in study and development of a new anti-cancer drug. We demonstrated the synthesis of AgNPs and its pharmaceutical importance using G. lucidum mycelial extract. Toxicity studies confirmed the potential Cytotoxic effects of biologically synthesized AgNPs in A549 and NCIH520 Lung cancer cells. AgNPs and Crude extract treated cells exhibited dose-dependent cell death. This study demonstrates the possibility of using AgNPs and polysaccharide extract to inhibit the growth of cancer cells and their cytotoxicity for potential therapeutic treatment. Application of AgNPs based on these findings may lead to valuable discoveries in pharmaceutical industries in developing new antitumor and antibacterial drugs.
Authors wish to thank Department of Experimental Medicine and Biotechnology of PGIMER, Chandigarh for their technical assistance.
(1.) Ahmad, A., Mukherjee, P., Senapati, S., Mandal, D., Khan, M.I., Kumar, R., Sastry, M. Extracellular biosynthesis of silver nanoparticles using the fungus Fusarium oxysporum. Colloids Surfaces B: Biointerfaces, 2003: 28(4): 313-318.
(2.) AshaRani, P.V., Low Kah Mun, G., Hande, M.P., Valiyaveettil, S. Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano., 2008: 3(2): 279-290.
(3.) Boh, B., Berovic, M., Zhang, J., Zhi-Bin, L. Ganoderma lucidum and its pharmaceutically active compounds. Biotechnol. Annu. Rev., 2007: 13: 265-301.
(4.) Borchers, A.T., Keen, C.L., Gershwin, M.E. Mushrooms, tumors, and immunity: an update. Exp. Biol. Med., 2004: 229(5): 393-406.
(5.) Borchers, A.T., Stern, J.S., Hackman, R.M., Keen, C.L., Gershwin, M.E. Mushrooms, tumors, and immunity. Proc Soc Exp Biol Med. Sep., 1999: 221(4): 281-293.
(6.) Burns, J.L., Saiman, L., Whittier, S., Larone, D., Krzewinski, J., Liu, Z., Marshall, S.A., Jones, R.N. Comparison of agar diffusion methodologies for antimicrobial susceptibility testing of Pseudomonas aeruginosa isolates from cystic fibrosis patients. J. Clin. Microbial., 2000: 38(5): 1818-1822.
(7.) Chang, R. Functional properties of edible mushrooms. Nutr Rev., 1996: 54(11): S91.
(8.) Chang, S.T. Global impact of edible and medicinal mushrooms on human welfare in the 21st century: nongreen revolution. Int. J. Med. Mushrooms, 1999: 1: 1-8.
(9.) Chang, Y.W., Lu, T. J. Molecular characterization of polysaccharides in hot-water extracts of Ganoderma lucidum fruiting bodies. J. Food Drug Anal., 2004: 12(1): 59-67.
(10.) Duran, N., Marcato, P.D., Alves, O.L., De Souza, G.I., Esposito, E. Mechanistic aspects of biosynthesis of silver nanoparticles by several Fusarium oxysporum strains. J. Nanobiotechnol., 2005: 3(8): 1-7.
(11.) Gopinath, P., Gogoi, S.K., Chattopadhyay, A., Ghosh, S.S. Implications of silver nanoparticle induced cell apoptosis for in vitro gene therapy. Nanotechnol., 2008: 19(7): 075104.
(12.) Gurunathan, S., Raman, J., Malek, S.N.A., John, P.A., Vikineswary, S. Green synthesis of silver nanoparticles using Ganoderma neo-japonicum Imazeki: a potential cytotoxic agent against breast cancer cells. Int. J. Nanomedicine, 2013: 8: 4399-4413.
(13.) Hemath Naveen, K.S., Kumar, G., Karthik, L., Bhaskara Rao, K.V Extracellular biosynthesis of silver nanoparticles using the filamentous fungus Penicillium sp. Arch. Appl. Sci. Res., 2010: 2: 161-167.
(14.) Hobbs, C. Medicinal Mushrooms. Botanica Press, Santa Cruz, CA, 1995.
(15.) Irshad, S., Mahmood, M., Perveen, F. In vitro antibacterial activities of three medicinal plants using agar well diffusion method. Res. J. Biol., 2012: 2: 1-8.
(16.) Karwa, A.S., Gaikwad, S., Rai, M.K. Mycosynthesis of silver nanoparticles using Lingzhi or Reishi medicinal mushroom, Ganoderma lucidum (W. Curt.: Fr.) P. Karst. and their role as antimicrobials and antibiotic activity enhancers. Int. J. Med. Mushrooms, 2011: 13(5): 483-491.
(17.) Kim, S. S., Kim, Y. S. Korean mushrooms. Yupoong Pub, Seoul, 1990.
(18.) Lindequist, U., Niedermeyer, T.H., Julich, W.D. The pharmacological potential of mushrooms. Evid. Based Complement Alternat. Med., 2005: 2(3): 285-299.
(19.) Manivasagan, P., Venkatesan, J., Senthilkumar, K., Sivakumar, K., Kim, S.K. Biosynthesis, antimicrobial and cytotoxic effect of silver nanoparticles using a novel Nocardiopsis sp. MBRC-1. BioMedRes. Int., 2013: ID 287638.
(20.) Masters R.W. Animal cell culture, Trypan Blue Assay sop. 3rd ed.,2000a: 1-3.
(21.) Masters R.W. Animal cell culture, Cytotoxicity and viability assays. 3rd ed., 2000b: 202-203.
(22.) Park, M.V, Neigh, A.M., Vermeulen, J.P., de la Fonteyne, L.J., Verharen, H.W., Briede, J.J., van Loveren, H., de Jong, W.H. The effect of particle size on the cytotoxicity, inflammation, developmental toxicity and genotoxicity of silver nanoparticles. Biomaterials, 2011: 32(36): 98109817.
(23.) Patel, S., Gheewala, N., Suthar, A., Shah, A. Invitro cytotoxicity activity of Solanum nigrum extract against Hela cell line and Vero cell line. Int. J. Pharm. Pharm. Sci., 2009: 1(1): 38-46.
(24.) Paterson, R.R.M. Ganoderma-a therapeutic fungal biofactory. Phytochemistry, 2006: 67(18): 1985-2001.
(25.) Phillips, H.J., Terryberry, J.E. Counting actively metabolizing tissue cultured cells. Exp. Cell Res., 1957: 13(2): 341-347.
(26.) Sanodiya, B.S., Thakur, G.S., Baghel, R.K., Prasad, G.B.K.S., Bisen, P.S. Ganoderma lucidum: a potent pharmacological macrofungus. Curr. Pharm. Biotechnol., 2009: 10(8): 717-742.
(27.) Sastry, M., Mayya, K.S., Bandyopadhyay, K. pH Dependent changes in the optical properties of carboxylic acid derivatized silver colloidal particles. Colloids Surfaces A: Physicochem. Eng. Asp, 1997: 127(1): 221-228.
(28.) Sastry, M., Patil, V., Sainkar, S.R. Electrostatically controlled diffusion of carboxylic acid derivatized silver colloidal particles in thermally evaporated fatty amine films. J. Phys. Chem. B, 1998: 102(8): 1404-1410.
(29.) Shiao, M. S., Lee, K. R., Lin, L. J., Wang, C. T. Natural products and biological activities of the Chinese medicinal fungus Ganoderma lucidum. In ACS symposium series (USA). Washington, 1994: 342-354.
(30.) Sliva, D. Ganoderma lucidum (Reishi) in cancer treatment. Integr Cancer Ther, 2003: 2(4): 358-364.
(31.) Vahabi, K., Mansoori, G.A., Karimi, S. Biosynthesis of silver nanoparticles by fungus Trichoderma reesei. Insciences J., 2011: 1: 65-79.
(32.) Zhao, Y., Nalwa, H.S. Nanotoxicology interactions of nanomaterials with biological systems, American Scienfici Publishers, California, USA, 2007.
(33.) Zhou, G., Wang, W. Synthesis of silver nanoparticles and their antiproliferation against human lung cancer cells in vitro. Orient. J. Chem., 2012: 28(2): 651-655.
Neha Bhardwaj , Priya Batra  and Vikas Beniwal *
 Department of Biotechnology, Maharishi Markandeshwar University, Mullana-133207, Ambala Haryana, India.
 Department of Microbiology, Punjab Agriculture University, Ludhiana-141004, Punjab, India.
(Received: 22 January 2016; accepted: 06 March 2016)
* To whom all correspondence should be addressed.
Tel.: +919416768062; Fax: +911731274375; E-mail: email@example.com
Caption: Fig. 1. Synthesis of silver nanoparticles (AgNPs) using G lucidum extract. (a) G lucidum mycelial polysaccharide extract. (b) Polysaccharide extract treated with AgNo3
Caption: Fig. 2. Effect of G lucidum mycelial polysaccharide extract on A549 cell line. a) A549 cell line inhibition b) A549 cell line viability
Caption: Fig. 3. Effect of silver ganoparticle (AgNPs) on A549 cell line. a) A549 cell line inhibition b) A549 Cell line viability
Caption: Fig 4. Effect of G. lucidum mycelial polysaccharide extract on NCIH 520 cell line. a) NCIH 520 cell line inhibition b) NCIH 520 cell line viability
Caption: Fig 5. Effect of silver ganoparticles (AgNPs) on NCIH 520 cell line. a) NCIH 520 cell line inhibition b) NCIH 520 cell line viability
Table 1. Percentage cell viability, cell density and live cell count Live Cell Lines Samples Cellcount 1. A549 Lung a) Control well 12.25 Cell Line Cancer b) Nanoparticle treated well. 6.75 c) Polysaccharide Extract treated well. 8.25 2. NCIH 520 Lung a) Control well 10.5 Cancer Cell Line b) Nanoparticle treated well. 5.25 c) Polysaccharide Extract treated well. 6.5 Cell Lines % Viability Cell Density 1. A549 Lung 100% 2.45x[10.sup.5] Cells/ml Cell Line Cancer 55% 1.4x[10.sup.5] Cells/ml 67.34% 1.7x[10.sup.5] Cells/ml 2. NCIH 520 Lung 100% 2.10x[10.sup.5] Cells/ml Cancer Cell Line 50% 1.1x[10.sup.5] Cells/ml 61.9% 1.3x[10.sup.5] Cells/ml Table 2. Antibacterial effect of Glucidum polysaccharide crude extract and silver ganoparticles (AgNPs) Test Organism Zone of Inhibition (Dia. In mm) Glucidum Glucidum Ganoparticles polysaccharide crude extract Staphylococcus aureus 19 22 Bacillus subtilis 18 20 Escherichia coli 16.5 19 Pseudomonas aeruginosa 15 18
|Printer friendly Cite/link Email Feedback|
|Author:||Bhardwaj, Neha; Batra, Priya; Beniwal, Vikas|
|Publication:||Journal of Pure and Applied Microbiology|
|Date:||Jun 1, 2016|
|Previous Article:||Dehydrogenase activity in the rhizosphre soils of sugarbeet.|
|Next Article:||Purification and characterization of extracellular lipase from pseudomonas aeruginosa KF 853103.|